Atlas Trials

Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors

Clinical trial NCT02838342 · COMPLETED

Trial details

NCT number
NCT02838342
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2015-05-19
Primary completion
2020-04-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.